Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates 2022-07-12 10:06
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
Industry Empowered by Science: Guangming Science City Lures Talent Globally 2022-07-08 15:38
Biotech Startup Noul Releases 2021 Sustainability Report 2022-07-08 15:00
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES 2022-07-08 09:28
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 2022-07-07 20:00
Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines 2022-07-07 17:45
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility 2022-07-07 08:00
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy 2022-07-06 23:00
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-07-06 19:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007 2022-07-06 12:00
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 2022-07-06 04:16
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement 2022-07-05 15:00
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities 2022-07-05 09:20
WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products 2022-07-05 08:30
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia 2022-07-04 22:14
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061 2022-07-04 13:34
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer 2022-07-01 22:00
Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918 2022-06-30 10:41
iNtRON to Seek a New Clinical Partner for SAL200 Endolysin 2022-06-28 21:00
1 74 75 76 77 78 220